Publications
5808 Results
- Journal / Conference
- Blood 124(21):1710; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
- Year
- 2014
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S9704
Double hit lymphoma and double positive lymphoma: subset analyses of MYC positive patients of SWOG S9704
- Journal / Conference
- Blood 124(21):395; American Society for Hematology (December 6-9, 2014, San Francisco, CA), oral;
- Year
- 2014
- Research Committee(s)
- Lymphoma
- Study Number(s)
- CTSU/9177
Preliminary report of a multicenter prospective phase II study of DA-EPOCH-R in MYC-rearranged aggressive B-cell lymphoma
- Journal / Conference
- Blood 124:4762; American Society for Hematology (December 6-9, 2014, San Francisco, CA), poster;
- Year
- 2014
- Research Committee(s)
- Myeloma
- Study Number(s)
- S1211
SWOG 1211: Initial report on phase I trial of RVD-Elouzumab for newly diagnosed high risk multiple myeloma (HRMM)
- Journal / Conference
- Journal of Clinical Oncology 32(27):2959-2967;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID25071121
- PMC
- PMC4162494
- Study Number(s)
- E1199, E2197
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
- Journal / Conference
- Journal of Clinical Pathology 67(9):777-780;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID24989024
- PMC
- PMC4145412
- Study Number(s)
- CTSU/R9804
Web based pathology assessment in RTOG 98-04
- Journal / Conference
- British Journal of Haematology 166(3):352-359
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24712482
- PMC
- PMC4299460
- Study Number(s)
- E1905
Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes
- Journal / Conference
- British Journal of Haematology 167(1):62-68;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24995683
- PMC
- PMC4299466
- Study Number(s)
- E1905
Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS
- Journal / Conference
- Pharmacogenomics Journal 214(5):424-431;
- Year
- 2014
- Research Committee(s)
- Lung
- PMID
- PMID24709690
- PMC
- pending
- Study Number(s)
- S0124
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
- Journal / Conference
- AACR Research International Conference on Frontiers on Cancer Research Prevention (Sept 28-Oct 1, 2014, New Orleans, LA; poster
- Year
- 2014
- Research Committee(s)
- Breast, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, Lymphoma, and Sarcoma
- Study Number(s)
- S0003, S0033, S0221, SWOG-8507, SWOG-8516 (INT-0067), SWOG-8600, SWOG-8706, SWOG-8736 (INT-0093), SWOG-8795 (INT-0094) (EST-1888), SWOG-8814, SWOG-8897, SWOG-8949, SWOG-9012, SWOG-9031, SWOG-9308, SWOG-9333, SWOG-9346, SWOG-9420, SWOG-9500, SWOG-9509, S9701, S9916
Association between BMI at treatment initiation and cancer survival across multiple SWOG trials
- Journal / Conference
- San Antonio Breast Cancer Symposium, abstr. [P3-11-16]; poster presentation;
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- S0800